Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

Changes in C-Reactive Protein and Complete Blood Cell Count According to Procalcitonin Levels

프로칼시토닌의 수준에 따른 C-반응성단백과 혈구산정검사의 변화

  • Kim, Jin-San (Department of Laboratory Medicine, Gangnam CHA Hospital) ;
  • Park, Chang-Eun (Department of Biomedical Laboratory Science, Molecular Diagnostics Research Institute, Namseoul University)
  • 김진산 (강남차병원 진단검사의학과) ;
  • 박창은 (남서울대학교 임상병리학과.분자진단연구소)
  • Received : 2022.02.18
  • Accepted : 2022.02.28
  • Published : 2022.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Procalcitonin (PCT) can provide an experimental rationale and a diagnostic lead to distinguish between bacterial and viral infections. This study sought to investigate the clinical characteristics and prognosis of patients with high PCT levels, to improve clinical diagnosis, and to determine whether PCT levels were associated with the subsequent development of sepsis in the general population. This was a retrospective observational study conducted on outpatients (N=127) over a year. The general data and laboratory parameters studied were PCT, C-reactive protein (CRP), and complete blood count (CBC). The positive rates of CRP and white blood cells (WBCs) in the elevated PCT group were higher than those of the normal group (P<0.05); the specificity and sensitivity of the PCT levels were obviously higher than those of the CRP and WBC levels at diagnosis (P<0.05). The mean PCT levels in the low group were significantly higher than those in the high or moderate group (P<0.001). There was a significant positive correlation with CRP, total WBCs, and neutrophils (P<.001). The main finding of this study was the significant association between an elevated PCT level and CRP and WBC levels, signifying a high diagnostic value. This has important implications for the diagnosis of bacterial infections and therapeutic implications for the use of antibiotic treatment in specific patients.

프로칼시토닌(procalcitonin, PCT)은 세균성과 바이러스성의 감염을 구별하기 위한 과학적 근거와 진단상의 중요한 단서를 제공한다. 프로칼시토닌이 높은 환자의 임상적 특성과 예후를 조사하고 임상적 진단을 향상시키고자 한다. 프로칼시토닌이 일반적인 집단에서 패혈증의 유병률과 연관성이 있는지를 결정한다. 이에 본 연구는 1년 동안 프로칼시토닌을 검사한 외래 환자(127명)의 C-반응성단백과 혈구산정검사의 결과를 기반으로 후향적 조사연구이다. 분석에 사용된 데이터는 프로칼시토닌, C-반응 단백 그리고 혈구산정검사이다. PCT의 결과가 높은 군의 CRP와 WBC의 양성율은 정상군보다 높게 나타났다(P<0.05). 프로칼시토닌 수준의 특이성과 민감도는 C-반응단백과 백혈구 수준보다 높게 나타났다(P<0.05). 또한. 프로칼시토닌의 결과값을 삼분위한 그룹의 분석에서는 낮은 군과 중간군의 값에 비해 높은 군의 값이 평균보다 높은 것으로 나타났다(P<.001). 상관분석에서는 프로칼시토닌은 C-반응단백, 백혈구(호중구, 림프구 포함)에서 양의 상관성을 보였다(P<.001). 이 연구의 주된 발견은 높은 프로칼시토닌은 C-반응성단백, 백혈구들의 수준에서 높은 연관성을 보이며 진단적 가치를 확인하였다. 따라서 이러한 관련 인자들은 환자의 감염진단과 항생제 치료에 중요한 진단적 및 치료적 영향을 미칠 것으로 사료된다.

Keywords

References

  1. Giannakopoulos K, Hoffmann U, Ansari U, Bertsch T, Borggrefe M, Akin I, et al. The use of biomarkers in sepsis: a systematic review. Curr Pharm Biotechnol. 2017;18:499-507. https://doi.org/10.2174/1389201018666170601080111
  2. Chen SY, Tsai CL, Lin CH, Lee CC, Chiang WC, Wang JL, et al. Impact of liver cirrhosis on mortality in patients with community-acquired bacteremia. Diagn Microbiol Infect Dis. 2009;64: 124-130. https://doi.org/10.1016/j.diagmicrobio.2009.01.008
  3. Gilbert DN. Role of procalcitonin in the management of infected patients in the intensive care unit. Infect Dis Clin North Am. 2017;31:435-453. https://doi.org/10.1016/j.idc.2017.05.003
  4. Taylor R, Jones A, Kelly S, Simpson M, Mabey J. A review of the value of procalcitonin as a marker of infection. Cureus. 2017; 9:e1148. https://doi.org/10.7759/cureus.1148
  5. Mitsuma SF, Mansour MK, Dekker JP, Kim J, Rahman MZ, Tweed-Kent A, et al. Promising new assays and technologies for the diagnosis and management of infectious diseases. Clin Infect Dis. 2013;56:996-1002. https://doi.org/10.1093/cid/cis1014
  6. Schuetz P, Aujesky D, Muller C, Muller B. Biomarker-guided personalised emergency medicine for all-hope for another hype? Swiss Med Wkly. 2015;145:w14079. https://doi.org/110.4414/smw.2015.14079
  7. Schuetz P, Raad I, Amin DN. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis. Curr Opin Crit Care. 2013;19: 453-460. https://doi.org/10.1097/MCC.0b013e328363bd38
  8. Lee CC, Chen SY, Tsai CL, Wu SC, Chiang WC, Wang JL, et al. Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department. Shock. 2008;29:322-327. https://doi.org/10.1097/shk.0b013e31815077ca
  9. Lin KH, Wang FL, Wu MS, Jiang BY, Kao WL, Chao HY, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis. Diagn Microbiol Infect Dis. 2014;80: 72-78. https://doi.org/10.1016/j.diagmicrobio.2014.03.029
  10. Muller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001;86:396-404. https://doi.org/10.1210/jcem.86.1.7089
  11. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000;181:176-180. https://doi.org/10.1086/315214
  12. Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Muller B. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med. 2004;32:1715-1721. https://doi.org/10.1097/01.ccm.0000134404.63292.71
  13. Limper M, de Kruif MD, Duits AJ, Brandjes DP, van Gorp EC. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect. 2010;60: 409-416. https://doi.org/10.1016/j.jinf.2010.03.016
  14. Lydon EC, Henao R, Burke TW, Aydin M, Nicholson BP, Glickman SW, et al. Validation of a host response test to distinguish bacterial and viral respiratory infection. EBioMedicine. 2019;48:453-461. https://doi.org/10.1016/j.ebiom.2019.09.040
  15. Park CE. Diagnosis and prognosis of sepsis. Korean J Clin Lab Sci. 2021;53:309-316. https://doi.org/10.15324/kjcls.2021.53.4.309
  16. Rast AC, Kutz A, Felder S, Faessler L, Steiner D, Laukemann S, et al. Procalcitonin improves the Glasgow Prognostic Score for outcome prediction in emergency patients with cancer: a cohort study. Dis Markers. 2015;2015:795801. https://doi.org/10.1155/2015/795801
  17. Hayashida K, Kondo Y, Hara Y, Aihara M, Yamakawa K. Head-to-head comparison of procalcitonin and presepsin for the diagnosis of sepsis in critically ill adult patients: a protocol for a systematic review and meta-analysis. BMJ Open. 2017;7:e014305. https://doi.org/10.1136/bmjopen-2016-014305
  18. Nguyen LJ, Varker A, Slaughter P, Boyle D, Nekahi N. Procalcitonin-guided antibiotic prescribing for acute exacerbations of chronic obstructive pulmonary disease in the Emergency Department. Fed Pract. 2021;38:264-269. https://doi.org/10.12788/fp.0141